Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:10 pm Purchase | 2025-06-30 | 13G | Blueprint Medicines Corporation BPMC | Pentwater Capital Management LP | 3,900,000 6.000% | 3,900,000![]() (New Position) | Filing History |
| 2025-08-14 1:07 pm Sale | 2025-06-30 | 13G | Blueprint Medicines Corporation BPMC | T. Rowe Price Associates, Inc. | 1,465,036 2.300% | -3,922,231![]() (-72.81%) | Filing History |
| 2025-08-14 07:18 am Sale | 2025-06-30 | 13G | Blueprint Medicines Corporation BPMC | Avoro Capital Advisors LLC | 375,000 0.600% | -3,475,000![]() (-90.26%) | Filing History |
| 2025-07-21 4:15 pm Unchanged | 2025-07-14 | 13G | Blueprint Medicines Corporation BPMC | Davidson Kempner Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-05-15 09:30 am Purchase | 2025-03-31 | 13G | Blueprint Medicines Corporation BPMC | Avoro Capital Advisors LLC | 3,850,000 6.000% | 3,850,000![]() (New Position) | Filing History |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | Blueprint Medicines Corporation BPMC | WELLINGTON MANAGEMENT GROUP LLP | 3,073,306 4.800% | -1,203,027![]() (-28.13%) | Filing History |
| 2025-04-23 8:19 pm Sale | 2025-03-31 | 13G | Blueprint Medicines Corporation BPMC | BlackRock Inc. BLK | 5,090,723 8.000% | -1,493,453![]() (-22.68%) | Filing History |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 2,247,679 3.500% | -2,100,632![]() (-48.31%) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | Blueprint Medicines Corporation BPMC | T. Rowe Price Associates, Inc. | 5,387,267 8.500% | -863,556![]() (-13.82%) | Filing History |
| 2024-04-10 12:58 pm Purchase | 2024-03-31 | 13G | Blueprint Medicines Corporation BPMC | T. Rowe Price Associates, Inc. | 6,250,823 10.200% | 815,206![]() (+15.00%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Blueprint Medicines Corporation BPMC | T. Rowe Price Associates, Inc. | 5,435,617 8.900% | 1,136,327![]() (+26.43%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 4,348,311 7.153% | -324,800![]() (-6.95%) | Filing History |
| 2024-02-08 10:11 am Sale | 2023-12-29 | 13G | Blueprint Medicines Corporation BPMC | WELLINGTON MANAGEMENT GROUP LLP | 4,276,333 7.030% | -727,095![]() (-14.53%) | Filing History |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | Blueprint Medicines Corporation BPMC | BlackRock Inc. BLK | 6,584,176 10.800% | 309,654![]() (+4.94%) | Filing History |
| 2024-01-10 10:16 am Purchase | 2023-12-29 | 13G | Blueprint Medicines Corporation BPMC | VANGUARD GROUP INC | 6,114,970 10.060% | 340,514![]() (+5.90%) | Filing History |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 4,673,111 7.687% | -4,301,434![]() (-47.93%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Blueprint Medicines Corporation BPMC | T. Rowe Price Associates, Inc. | 4,299,290 7.200% | -251,249![]() (-5.52%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Blueprint Medicines Corporation BPMC | VANGUARD GROUP INC | 5,774,456 9.650% | 240,685![]() (+4.35%) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Blueprint Medicines Corporation BPMC | FMR LLC | 8,974,545 14.999% | 2,941,866![]() (+48.77%) | Filing History |
| 2023-02-06 2:49 pm Purchase | 2022-12-30 | 13G | Blueprint Medicines Corporation BPMC | WELLINGTON MANAGEMENT GROUP LLP | 5,003,428 8.360% | 1,526,103![]() (+43.89%) | Filing History |

